IgA Nephropathy and Related Diseases

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-415847-4.00105-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• IgA nephropathy: molecular mechanisms of the disease.

  2013influential reference
• Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

  2013cited by this paper
• Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen*

  2012cited by this paper
• The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.

  2012cited by this paper
• Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

  2012cited by this paper
• The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

  2012cited by this paper
• The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.

  2012cited by this paper
• In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.

  2012cited by this paper
• Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma

  2012influential reference
• Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford Classification patient cohort.

  2012cited by this paper
• Naturally occurring structural isomers in serum IgA1 o-glycosylation.

  2012cited by this paper
• Implementation of proteomic biomarkers: making it work

  2012cited by this paper
• Glycosylation of IgA1 and pathogenesis of IgA nephropathy

  2012influential reference
• Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.

  2012cited by this paper
• Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.

  2012cited by this paper
• Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy

  2012cited by this paper
• Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

  2012cited by this paper
• Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.

  2012influential reference
• An update on the pathogenesis and treatment of IgA nephropathy.

  2012cited by this paper
• Genome-wide association study identifies susceptibility loci for IgA nephropathy

  2011cited by this paper
• The pathophysiology of IgA nephropathy.

  2011influential reference
• Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.

  2011cited by this paper
• Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy.

  2011cited by this paper
• Emerging Paradigms for the Initiation of Mucin-type Protein O-Glycosylation by the Polypeptide GalNAc Transferase Family of Glycosyltransferases*

  2011cited by this paper
• The Tn Antigen—Structural Simplicity and Biological Complexity

  2011influential reference
• Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.

  2011cited by this paper
• Current therapy for IgA nephropathy.

  2011cited by this paper
• IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.

  2011influential reference
• A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy

  2011cited by this paper
• Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.

  2011cited by this paper
• Familial IgA nephropathy in southeastern Kentucky.

  2010cited by this paper
• Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease*

  2010cited by this paper
• Expression of Homing Receptors on IgA1 and IgA2 Plasmablasts in Blood Reflects Differential Distribution of IgA1 and IgA2 in Various Body Fluids

  2010cited by this paper
• Clustered O-Glycans of IgA1

  2010cited by this paper
• Genetic studies of IgA nephropathy: past, present, and future

  2010cited by this paper
• SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity

  2010cited by this paper
• Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

  2010cited by this paper
• Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

  2010influential reference
• Down-regulation of core 1 β1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1

  2010cited by this paper
• Comprehensive human urine standards for comparability and standardization in clinical proteome analysis

  2010influential reference
• HLA has strongest association with IgA nephropathy in genome-wide analysis.

  2010influential reference
• DEFINING MACRO- AND MICROHETEROGENEITY BY USE OF ELECTRON CAPTURE/TRANSFER DISSOCIATION* □ S

  2010cited by this paper
• Cosmc is an essential chaperone for correct protein O-glycosylation

  2010cited by this paper
• Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.

  2009cited by this paper
• The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses*

  2009cited by this paper
• The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

  2009cited by this paper
• Comparison of Methods for Profiling O-Glycosylation

  2009cited by this paper
• Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease

  2009cited by this paper
• Application of proteomic analysis to renal disease in the clinic

  2009cited by this paper
• Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments.

  2009cited by this paper
• IgA Immune-Complex

  2009influential reference
• Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

  2009influential reference
• Secondary IgA nephropathy.

  2008influential reference
• IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

  2008influential reference
• Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy.

  2008cited by this paper
• External suppression causes the low expression of the Cosmc gene in IgA nephropathy.

  2008cited by this paper
• No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients.

  2008cited by this paper
• B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy.

  2008cited by this paper
• Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

  2008cited by this paper
• Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.

  2008cited by this paper
• Urinary proteomics in diabetes and CKD.

  2008cited by this paper
• Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

  2008cited by this paper
• Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

  2008influential reference
• IgA nephropathy and Henoch–Schönlein purpura nephritis

  2008cited by this paper
• Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.

  2008cited by this paper
• Toll-like receptor 9 affects severity of IgA nephropathy.

  2008cited by this paper
• Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.

  2007cited by this paper
• Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.

  2007cited by this paper
• Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.

  2007cited by this paper
• Fcα receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcRγ adaptor

  2007cited by this paper
• Electrophoretic methods for analysis of urinary polypeptides in IgA‐associated renal diseases

  2007cited by this paper
• Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura

  2007cited by this paper
• The genetics of IgA nephropathy

  2007cited by this paper
• Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.

  2007cited by this paper
• Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

  2007influential reference
• Advances in urinary proteome analysis and biomarker discovery.

  2007cited by this paper
• The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.

  2007cited by this paper
• IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

  2007cited by this paper
• Synthesis of TNF-α by mesangial cells cultured with polymeric anionic IgA—role of MAPK and NF-κB

  2007cited by this paper
• Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy

  2007cited by this paper
• O-glycosylation of serum IgD in IgA nephropathy.

  2006cited by this paper
• Brief Communication: Glomerulonephritis in Patients with Hepatitis C Cirrhosis Undergoing Liver Transplantation

  2006cited by this paper
• Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study.

  2006cited by this paper
• O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.

  2006cited by this paper
• IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.

  2005influential reference
• Peripheral B lymphocyte β1,3‐galactosyltransferase and chaperone expression in immunoglobulin A nephropathy

  2005cited by this paper
• Determination of Aberrant O-Glycosylation in the IgA1 Hinge Region by Electron Capture Dissociation Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry*

  2005cited by this paper
• Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.

  2005cited by this paper
• Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals

  2005cited by this paper
• IgA nephropathy.

  2005cited by this paper
• Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.

  2005cited by this paper
• Protein glycosylation: Chaperone mutation in Tn syndrome

  2005cited by this paper
• Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.

  2004cited by this paper
• Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry.

  2004cited by this paper
• IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli

  2004cited by this paper
• Systemic immune response after mucosal immunization in patients with IgA nephropathy

  2004cited by this paper
• IgA nephritis in a child with human immunodeficiency virus: a unique form of human immunodeficiency virus-associated nephropathy?

  2004cited by this paper
• Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy

  2004cited by this paper
• Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome.

  2004cited by this paper
• Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases

  2004cited by this paper

• The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy

  2016cites this paper
• CiRCULATiNG igA-CONTAiNiNG iMMUNe COMPLeXeS iN igA NePHROPATHY AND HeNOCH – SCHÖNLeiN PURPURA NePHRiTiS

  2016cites this paper
• Mucosal immune defense

  2014cites this paper
• in Immunology In vitro -generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells

  2013cites this paper